XML 56 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity
 12 Months Ended
Dec. 31, 2012
Stockholders' Equity [Abstract]  
STOCKHOLDERS' EQUITY

(12) STOCKHOLDERS’ EQUITY

In the first quarter of 2012, the Company issued 266,478 shares of restricted common stock of the Company valued at $158 related to its acquisition of NeuroDyne (see Note 5).

During 2012, 34,500 shares of common stock were issued for cash of $13, upon the exercise of stock options. During 2012, 5,625 shares of common stock were issued upon the cashless exercise of 50,000 non-employee warrants. During 2011, 112,500 shares of common stock were issued for cash of $48 upon the exercise of stock options. During 2012 and 2011, 25,000 and 99,964 shares of common stock were issued to individuals as non-cash compensation for services rendered, valued at approximately $20 and $79 (based on the market price of the Company’s common stock on the date of the grants).

 

For stock warrants or options granted to non-employees, the Company measures fair value of the equity instruments utilizing the Black-Scholes method if that valuation method results in a more reliable measurement than the fair value of the consideration or the services received. For stock granted, the Company measures fair value of the shares issued utilizing the market price of the shares on the date the transaction takes place. The Company amortizes such costs over the related period of service.